Rhythm Pharmaceuticals Reaches Analyst Target Price
January 29, 2018 at 10:15 AM EST
In recent trading, shares of Rhythm Pharmaceuticals Inc (RYTM) have crossed above the average analyst 12-month target price of $31.25, changing hands for $31.87/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..